Technology and Equipment

Accelerating the progress of cell and gene therapies with decentralized trials and other innovative approaches.

AI helps make preclinical decisions faster, but stakeholders remain cautious. We asked an expert from Elsevier for their views on the challenges.

Understanding the role of spatially offset Raman spectroscopy in identifying raw materials, counterfeit medicines, and more.

AI is not just for the drug development phase of pharmaceutical manufacturing. Now is the time for the business side to leverage it.

A selection of experts from Asahi Kasei Bioprocess discuss the key practices behind successful processes.

Cell and Gene therapies have come a long way since the 1970s. Technology, combined with knowledge, will take them even further.

We find out why Cas12l incorporated into a gene-writing system could help advance the field of gene editing.

Clinical trials can be needlessly complex – which impacts the bottom line of trial sponsors. It’s time for change.

A look back at The Medicine Maker archive and the influence of science fiction in the industry and science.

A partnership between WhiteLab Genomics and Debiopharm will seek to use AI to streamline the development of targeted cancer therapies.